Phase II Study of Carboplatin, Paclitaxel, and Bevacizumab With Maintenance Bevacizumab As First-Line Chemotherapy for Advanced Mullerian Tumors

Penson, R. T.; Dizon, D. S.; Cannistra, S. A.; Roche, M. R.; Krasner, C. N.; Berlin, S. T.; Horowitz, N. S.; DiSilvestro, P. A.; Matulonis, U. A.; Lee, H.; King, M. A.; Campos, S. M.

期刊名称Journal of Clinical Oncology
作者Penson, R. T.; Dizon, D. S.; Cannistra, S. A.; Roche, M. R.; Krasner, C. N.; Berlin, S. T.; Horowitz, N. S.; DiSilvestro, P. A.; Matulonis, U. A.; Lee, H.; King, M. A.; Campos, S. M.
卷第28卷
期第1期
印刷ISSN0732-183X
电子ISSN1527-7755
文件大小139.76KB
发表时间2010-01-01
DOI10.1200/JCO.2009.22.7900
页码154-159

发现好书期刊，享受阅读乐趣

Phase II Study of Carboplatin, Paclitaxel, and Bevacizumab With Maintenance Bevacizumab As First-Line Chemotherapy for Advanced Mullerian Tumors